| 000 | 00951 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517121726.0 | ||
| 264 | 0 | _c20180816 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a2168-6157 | ||
| 024 | 7 |
_a10.1001/jamaneurol.2016.3916 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReilmann, Ralf | |
| 245 | 0 | 0 |
_aDeutetrabenazine-Not a Revolution but Welcome Evolution for Treating Chorea in Huntington Disease. _h[electronic resource] |
| 260 |
_bJAMA neurology _c12 2016 |
||
| 300 |
_a1404-1406 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHuntington Disease _xdrug therapy |
| 650 | 0 | 4 |
_aNeurotransmitter Uptake Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aTetrabenazine _xanalogs & derivatives |
| 773 | 0 |
_tJAMA neurology _gvol. 73 _gno. 12 _gp. 1404-1406 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamaneurol.2016.3916 _zAvailable from publisher's website |
| 999 |
_c26523560 _d26523560 |
||